The UCLA Clinical Genomics Center’s 3rd Annual Symposium will provide important information about the appropriate clinical application of whole genome technologies including whole exome sequencing and Single-Nucleotide Polymorphism (SNP) chromosomal microarray analysis. A distinguished roster of speakers will discuss how these technologies are used to identify specific mutations in particular Mendelian and somatic disorders. Experts in a variety of disorders will highlight examples of improved patient outcomes using these definitive diagnostic approaches. The event will include a discussion of the highly complex ethical considerations associated with this extraordinary diagnostic opportunity and its impact and a mock case evaluation by the Exome Sequencing Genomic Data Board.